2024-05-10 06:16:10
Golidocitinib Granted Priority Review by China NMPA for the Treatment of r/r PTCL
Health/ 2023-09-26
Golidocitinib Granted Priority Review by...

SHANGHAI,Sept. 21,2023-- Dizal announced today that the China National Medical Products Administration (NMPA) has granted priority review st...

Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
Health/ 2023-09-26
Inmagene announces formation of Celexor ...

SAN DIEGO,Sept. 21,2023--Inmagene Biopharmaceuticals (Inmagene),a clinical-stage biotech company developing innovative and differentiated th...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release